Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-009067

CVP, Chief Financial Officer sold 13,000 shares at an average $83.08 ($1,080,093)

  • CVP, Chief Financial Officer acquired 13,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ullem Scott B. · CVP, Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-10 Exercise or conversion : show line 1 in the form 10b5-1 +13,000 $59.26 $770,337 52,898 D
2025-11-10 Sale : show line 2 in the form 10b5-1 −2,974 $83.30 $247,734 49,924 D
2025-11-10 Sale : show line 3 in the form 10b5-1 −10,026 $83.02 $832,360 39,898 D
Open-market sales · 13,000 sh · avg $83.08 · $1,080,093

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-10 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −13,000 46,700 D
Loading xslF345X05/doc4.xml…